Compound Profile and Research Applications
Turinabol (4-chlorodehydromethyltestosterone) is an anabolic androgenic steroid originally synthesised in the 1960s for pharmaceutical research. This chlorinated derivative of metandienone features a unique molecular structure that researchers at Stroid UK Shop examine for its distinctive androgenic-anabolic dissociation properties. Para Pharma’s 20mg formulation provides laboratory-grade material for investigating steroid receptor binding mechanisms and tissue-selective anabolic activity patterns. Research institutions utilise this compound to analyse the effects of 4-chloro substitution on steroid bioactivity profiles compared to traditional anabolic agents available through our turinabol research collection.
Laboratory Investigation Protocols
Contemporary research programmes examine Turinabol’s modified A-ring structure to understand how halogen substitution influences steroid-receptor interactions in muscle and bone tissue models. Scientists investigate this compound’s reduced hepatotoxicity profile relative to methylated analogues, making it valuable for extended cellular viability studies. The oral bioavailability characteristics enable researchers to compare absorption kinetics with other synthetic androgens, while its moderate androgenic properties provide reference data for tissue-selectivity investigations. Advanced studies explore the compound’s effects on protein synthesis pathways and nitrogen retention mechanisms in controlled laboratory environments, complementing broader research portfolios that include selective androgen receptor modulators and peptide compounds.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | 4-chlorodehydromethyltestosterone |
| Concentration | 20mg per tablet |
| CAS Number | 2446-23-3 |
| Molecular Formula | C₂₀H₂₇ClO₂ |
| Molecular Weight | 334.88 g/mol |
| Manufacturer | Para Pharma |
| Form | Oral tablets |
| Storage Conditions | Room temperature, dry location |
Research Compliance Statement
This Turinabol product is manufactured by Para Pharma exclusively for in-vitro laboratory research applications. Not approved for human consumption, clinical trials, or therapeutic applications. Researchers must operate under appropriate institutional oversight and maintain proper laboratory safety protocols during all investigational procedures involving this anabolic steroid compound.
